Rocket Lab’s Gravity Check: A $266 Million Air Force Win Can’t Halt a Sector-Wide Selloff

Rocket Lab's stock drops 8.3% on SpaceX capacity news, despite securing major defense contracts and pursuing a transformative Iridium acquisition.

Rocket Lab has spent the past year behaving less like a scrappy launch startup and more like a defense prime. It secured a fixed-price, $266 million U.S. Air Force contract for a dozen suborbital Electron missions from Alaska’s Pacific Spaceport Complex through December 2028 — building on a $190 million award earlier this year. It joined the Space Force’s NSSL Phase 3 Lane 1 program, one of seven approved vendors for national security launches tied to a $17 billion procurement ceiling. The NASA pipeline added two more missions, PolSIR and TSIS-2, collectively worth under $30 million but reinforcing a client roster that now reads like a government directory.

None of that stopped the stock from shedding 8.29 percent on Friday to close at €56.40, extending a monthly rout that now totals 24.9 percent. The 52-week high of €133.80, set as recently as May 27, sits 57.85 percent above current levels. The 14-day relative strength index has fallen to 30.8, flirting with oversold territory, while annualized 30-day volatility clocks in at 88.21 percent — a reminder that this is a stock as much for traders as for long-term holders.

A SpaceX Headwind, Not a Rocket Lab Problem

The trigger for Friday’s drop came from Boca Chica, not Long Beach. Reports emerged that SpaceX has stopped accepting new bookings for dedicated Falcon 9 launches beyond 2028 and closed its rideshare program to fresh reservations. The company has also halted production of certain non-reusable Falcon components. The news rippled across the space sector, amplified by pre-launch jitters ahead of a closely watched Starship test flight. AST SpaceMobile fell 4 percent to $56.94 on the same session.

Analysts were quick to note that neither company generated its own negative catalyst — the selloff was sympathetic, not fundamental. Some observers see a potential silver lining: if SpaceX is genuinely hitting capacity constraints on Falcon 9, Rocket Lab’s reusable Neutron rocket could find a ready pool of displaced customers. A recent successful engine test for Neutron adds credibility to that timeline, and any further delays to Starship would only widen the window.

The Iridium Wildcard and the Integration Risk

The strategic centerpiece of Rocket Lab’s transformation remains the planned acquisition of Iridium Communications, announced in late June at $54 per Iridium share in a cash-and-stock mix. The deal aims to fuse Rocket Lab’s launch and spacecraft manufacturing business with Iridium’s low-Earth-orbit satellite network, creating a vertically integrated space company that designs, builds, launches, and operates its own constellations.

Shareholder and regulatory approvals are still pending, with a close expected by mid-2026. The transaction carries the kind of long-term optionality that could redefine Rocket Lab’s earnings profile years from now. In the near term, however, it adds integration risk at precisely the moment when nervous investors are repricing the entire sector. Insider sales, broad risk aversion, and rotation out of space stocks following the SpaceX IPO have compounded the pressure.

Record Revenue Meets a Brutal Month

The disconnect between operational momentum and stock price is stark. Rocket Lab reported first-quarter 2026 revenue of just over $200 million, a 63.5 percent year-over-year increase. Its backlog swelled to $2.2 billion, fueled by 31 new launch contracts in a single quarter — more than the company signed in all of the previous year. Management guided for second-quarter revenue of up to $240 million.

On a 12-month basis, the stock is still up 37.56 percent, a testament to how steep the rally was before the May peak. The consensus analyst price target stands at €100.53, implying 78.2 percent upside from Friday’s close. Stifel characterized the Air Force contract as validation that the HASTE hypersonic test platform is operationally relevant, particularly as Washington accelerates its hypersonic weapons push.

Earnings Will Settle the Debate

Rocket Lab is scheduled to report second-quarter results after the close on August 10, 2026. The report will need to demonstrate that backlog growth and contract momentum are advancing fast enough to offset the capital intensity of two simultaneous undertakings: ramping up Neutron production and digesting a multibillion-dollar acquisition.

The stock’s slide over the past month looks less like a company-specific indictment and more like a sector-wide repricing. Space and defense-adjacent names were broadly volatile through July, and Rocket Lab’s trajectory has tracked that retreat at least as much as any single corporate development. Whether the current level represents a buying opportunity or a warning about execution risk will depend on what the numbers show — and whether the narrative can reassert itself over the gravity of the chart.